J Drugs Dermatol. 2024 May 1;23(5):327-331. doi: 10.36849/JDD.8003.
Though it is widely acknowledged that cancer treatments cause hair loss on the scalp, there are limited data on how they affect eyebrow and eyelash hairs. Patients with eyebrow and eyelash loss, or madarosis, seek various treatment options ranging from camouflage techniques with makeup, permanent tattoos, and prescription medications. Though not yet studied in patients with cancer-induced madarosis, techniques such as scalp cooling, cryotherapy, and topical vasoconstrictors are promising preventative options. More robust research is needed to improve both the quality and quantity of available treatment and preventative options. There is a clear need for dermatologists to play a role in supportive oncodermatology for patients who experience eyebrow and eyelash loss secondary to chemotherapy, endocrine therapies, and radiation therapy. J Drugs Dermatol. 2024;23(5):327-331. doi:10.36849/JDD.8003.
尽管人们普遍认为癌症治疗会导致头皮脱发，但关于它们如何影响眉毛和睫毛的信息有限。眉毛和睫毛缺失（即眉毛和睫毛脱落症，madarosis）的患者会寻求各种治疗选择，包括化妆遮瑕技术、永久性纹身和处方药物。尽管尚未在癌症引起的眉毛和睫毛脱落症患者中进行研究，但头皮冷却、冷冻疗法和局部血管收缩剂等技术作为有希望的预防选择。需要更有力的研究来改善现有治疗和预防选择的质量和数量。对于因化疗、内分泌治疗和放射治疗而出现眉毛和睫毛脱落的患者，皮肤科医生在支持性肿瘤皮肤科方面发挥着重要作用。J 皮肤病学杂志。2024;23(5):327-331.doi:10.36849/JDD.8003.
